Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Changes in access to viral load testing, incidence rates of viral load suppression and rebound following the introduction of the 'universal test and treat' guidelines in Cameroon: A retrospective follow-up analysis.
Bekolo CE, Ndeso SA, Moifo LL, Mangala N, Ateudjieu J, Kouanfack C, Dzudie A, Thienemann F, Tendongfor N, Nsagha DS, Choukem SP. Bekolo CE, et al. Among authors: kouanfack c. PLOS Glob Public Health. 2024 Apr 16;4(4):e0003042. doi: 10.1371/journal.pgph.0003042. eCollection 2024. PLOS Glob Public Health. 2024. PMID: 38626049 Free PMC article.
Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM).
Liégeois F, Boyer S, Eymard-Duvernay S, Carrieri P, Kouanfack C, Domyeum J, Maradan G, Ducos J, Mpoudi-Ngolé E, Spire B, Delaporte E, Kuaban C, Vidal L, Laurent C; EVOLCAM study group. Liégeois F, et al. Among authors: kouanfack c. BMC Infect Dis. 2020 Jan 15;20(1):49. doi: 10.1186/s12879-020-4784-7. BMC Infect Dis. 2020. PMID: 31941464 Free PMC article.
Acceptability and Feasibility of the Plasma Separation Card for an Integrated Model of Care for HBV and HCV Screening Among People Attending HIV Clinics in Cameroon and Uganda.
Picchio CA, Nicolàs A, Ayemfouo Fofou IV, Kasone V, Guewo-Fokeng M, Tagny CT, Nanyonjo T, Nansumba H, Kouongni YN, Sezawo Kamdjeu RGE, Seremba E, Kouanfack C, Ssewanyana I, Njouom R, Segura AR, Rodríguez-Frías F, Mbanya JC, Ocama P, Lazarus JV. Picchio CA, et al. Among authors: kouanfack c. J Epidemiol Glob Health. 2024 Sep;14(3):827-838. doi: 10.1007/s44197-024-00220-w. Epub 2024 Mar 27. J Epidemiol Glob Health. 2024. PMID: 38536619 Free PMC article.
The Feasibility and Acceptability of Using Mobile Applications for HIV Testing, Prevention, and Treatment Among Adolescent Girls and Young Women in Cameroon: A Cross-Sectional Study.
Ndenkeh JJN, Nelson LE, Bogning A, Yumo H, Bediang G, Njih E, Fotso D, Abu-Ba'are GR, Kouanfack C, Ni Z. Ndenkeh JJN, et al. Among authors: kouanfack c. J Assoc Nurses AIDS Care. 2024 May-Jun 01;35(3):210-221. doi: 10.1097/JNC.0000000000000469. Epub 2024 Apr 3. J Assoc Nurses AIDS Care. 2024. PMID: 38569188 Free PMC article.
Prevalence, Epidemiological, and Clinical Profile of Patients Coinfected with Human Immunodeficiency Virus and Tuberculosis in the Coronavirus Disease 2019 Context in Health Facilities in the East Region, Cameroon.
François Anicet OA, Kouanfack C, Dama U, Nkfusai CN, Abanda JN, Tchoffo D, Mbu PN, Yoniene PY. François Anicet OA, et al. Among authors: kouanfack c. Int J MCH AIDS. 2024 Apr 23;13:e006. doi: 10.25259/IJMA_683. eCollection 2024. Int J MCH AIDS. 2024. PMID: 38742165 Free PMC article.
SARS-CoV-2 cross-sectional serosurvey across three HIV-1 therapeutic clinical trials in Africa.
Papot E, Tovar-Sanchez T, Woods J, Thaurignac G, Eriobu N, Borok M, Kaplan R, Avihingsanon A, Azwa I, Grinsztejng B, Kumarasamy N, Sokhela S, Mpoudi-Etame M, Arriaga M, Jacoby S, Matthews GV, Losso MH, Khoo S, Calmy A, Kouanfack C, Ayouba A, Petoumenos K, Venter WDF, Delaporte E, Polizzotto MN; COHIVE study group (COHIVE consortium includes ADVANCE, DolPHIN2, D2EFT and NAMSAL study groups). Papot E, et al. Among authors: kouanfack c. AIDS. 2024 Nov 22. doi: 10.1097/QAD.0000000000004068. Online ahead of print. AIDS. 2024. PMID: 39576151
Feasibility, safety, efficacy and potential scaling-up of sofosbuvir-based HCV treatment in Central and West Africa: (TAC ANRS 12311 trial).
Lacombe K, Moh R, Chazallon C, Lemoine M, Sylla B, Fadiga F, Le Carrou J, Marcellin F, Kouanfack C, Ciaffi L, Sartre MT, Sida MB, Diallo A, Gozlan J, Seydi M, Cissé V, Danel C, Girard PM, Toni TD, Minga A, Boyer S, Carrieri P, Attia A; TAC ANRS12311 Study Group. Lacombe K, et al. Among authors: kouanfack c. Sci Rep. 2024 May 3;14(1):10244. doi: 10.1038/s41598-024-57013-1. Sci Rep. 2024. PMID: 38702350 Free PMC article. Clinical Trial.
Durability of the Efficacy and Safety of Dolutegravir-Based and Low-Dose Efavirenz-Based Regimens for the Initial Treatment of Human Immunodeficiency Virus Type 1 Infection in Cameroon: Week 192 Data of the NAMSAL-ANRS-12313 Study.
Mpoudi-Etame M, Tovar Sanchez T, Bousmah MA, Omgba Bassega P, Olinga J, Mimbe E, Foalem M, Chiep C, Edimo S, Varloteaux M, Pelloquin R, Lamare N, Boyer S, Peeters M, Reynes J, Calmy A, Hill A, Delaporte E, Kouanfack C; New Antiretroviral and Monitoring Strategies in HIV-infected Adults in Low-income countries (NAMSAL-ANRS-12313) study group. Mpoudi-Etame M, et al. Among authors: kouanfack c. Open Forum Infect Dis. 2023 Nov 20;10(12):ofad582. doi: 10.1093/ofid/ofad582. eCollection 2023 Dec. Open Forum Infect Dis. 2023. PMID: 38156046 Free PMC article.
131 results